Literature DB >> 20602236

Reversible dyscognition in patients with a unilateral, middle fossa arachnoid cyst revealed by using a laptop based neuropsychological test battery (CANTAB).

Johan Torgersen1, Christian Helland, Hans Flaatten, Knut Wester.   

Abstract

The aim of this study was to evaluate and validate the Cambridge Neuropsychological Test Automated Battery (CANTAB) in a Norwegian group of patients undergoing surgery for middle fossa arachnoid cysts (AC). We also wanted to assess health related quality of life (HRQOL) in these patients to see if it could be improved by decompression of the AC. Adult patients (>18 years) with unilateral middle fossa AC and no previous history of neurological disease, head injury, or a psychiatric disorder were eligible for inclusion. We used four tests from CANTAB to assess the level of neuropsychological performance: paired associate learning (PAL) and delayed matching to sample (DMS) assessed temporal lobe functions, while Stockings of Cambridge (SOC) and intra-extra dimensional (IED) shift focused on frontal lobe functions. Patients with postoperative cerebral complications were reported, but excluded from neuropsychological follow-up. In addition to the CANTAB data, pre- and postoperative clinical and radiological data were collected. HRQOL was assessed using Short Form 36 (SF-36) pre- and postoperatively. We found significant improvement in the two temporal tests assessing memory, but no improvement in the two frontal tests assessing executive function. HRQOL was significantly reduced preoperatively in two of eight SF-36 domains and improved significantly in four domains postoperatively. CANTAB facilitates detection of cognitive improvements after decompression of the cyst in patients with AC in the middle fossa. The improvements were detected on the tests sensitive to temporal lobe problems only, not on the tests more sensitive to frontal lobe affection. This establishes construct validity for CANTAB for the first time in this population.

Entities:  

Mesh:

Year:  2010        PMID: 20602236     DOI: 10.1007/s00415-010-5634-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

Authors:  A M Owen; R G Morris; B J Sahakian; C E Polkey; T W Robbins
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

2.  Hydrocephalus in children with middle fossa arachnoid cysts.

Authors:  Michael L Levy; Hal S Meltzer; Samuel Hughes; Henry E Aryan; Kevin Yoo; Arun Paul Amar
Journal:  J Neurosurg       Date:  2004-08       Impact factor: 5.115

3.  Short form 36 (SF-36) health survey: normative data from the general Norwegian population.

Authors:  J H Loge; S Kaasa
Journal:  Scand J Soc Med       Date:  1998-12

4.  Cognitive improvement despite minimal arachnoid cyst decompression.

Authors:  V M Soukup; J Patterson; T T Trier; J W Chen
Journal:  Brain Dev       Date:  1998-12       Impact factor: 1.961

5.  A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery.

Authors:  T W Robbins; M James; A M Owen; B J Sahakian; A D Lawrence; L McInnes; P M Rabbitt
Journal:  J Int Neuropsychol Soc       Date:  1998-09       Impact factor: 2.892

6.  Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

Authors:  A M Owen; A C Roberts; C E Polkey; B J Sahakian; T W Robbins
Journal:  Neuropsychologia       Date:  1991       Impact factor: 3.139

7.  The utility of the recognition memory test and the graded naming test for monitoring neurological patients.

Authors:  Chris M Bird; Lisa Cipolotti
Journal:  Br J Clin Psychol       Date:  2007-06

8.  Verbal laterality and handedness in patients with intracranial arachnoid cysts.

Authors:  Knut Wester; Kenneth Hugdahl
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

9.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.

Authors:  B C Beats; B J Sahakian; R Levy
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

10.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501

View more
  5 in total

1.  Changes of quality of life and cognitive function in individuals with Internet gaming disorder: A 6-month follow-up.

Authors:  Jae-A Lim; Jun-Young Lee; Hee Yeon Jung; Bo Kyung Sohn; Sam-Wook Choi; Yeon Jin Kim; Dai-Jin Kim; Jung-Seok Choi
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

2.  Reversal of cognitive, behavioral, and language impairments after the left frontal arachnoid cyst fenestration in a pediatric patient.

Authors:  Christina R Maxwell; Neal Joshi; Christina N Feller; Michael McAree; Hirad S Hedayat
Journal:  Surg Neurol Int       Date:  2021-07-27

Review 3.  COGNITIVE AND PSYCHOTIC SYMPTOMS IN A PATIENT WITH INFRATENTORIAL ARACHNOID CYST: CASE REPORT.

Authors:  Maja Škarić; Branka Aukst Margetić; Anamarija Bogović Dijaković; Dalibor Karlović
Journal:  Acta Clin Croat       Date:  2021-06       Impact factor: 0.780

4.  Retinal Thickness Associates with Cognition Dysfunction in Young Adult with Type 1 Diabetes in Taiwan.

Authors:  Jung-Lung Hsu; Pei-Shin Gu; Eugene Yu-Chuan Kang; Chi-Chun Lai; Fu-Sung Lo
Journal:  J Diabetes Res       Date:  2022-09-26       Impact factor: 4.061

5.  Intracranial arachnoid cysts: impairment of higher cognitive functions and postoperative improvement.

Authors:  Priyanthi B Gjerde; Marit Schmid; Asa Hammar; Knut Wester
Journal:  J Neurodev Disord       Date:  2013-08-28       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.